PR PolyResearch

Join Free

NYSE

MetLife, Inc. (MET)

♥ 400 Thanks from members

MetLife, Inc. (MET) demonstrates robust Q2 2026 performance with a 20% year-over-year EPS beat, driven by strong investment income, favorable underwriting, and volume growth, maintaining a balanced buy-case sentiment supported by strategic capital returns.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other NYSE Tickers

Rayonier Inc. REIT (RYN)

Blackstone Inc. (BX)

Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor) American Depositary Shares (EDN)

Miami International Holdings, Inc. (MIAX)

Bob's Discount Furniture, Inc. (BOBS)

USANA Health Sciences, Inc. (USNA)